Clinical Relapse Common After Infliximab Withdrawal in Ankylosing Spondylitis
Medical Health News,
Nearly two-thirds of patients with (AS) who achieved clinical remission on demonstrated symptom flares and clinical relapse…
Nearly two-thirds of patients with (AS) who achieved clinical remission on demonstrated symptom flares and clinical relapse…
Approximately 58% of patients in clinical remission after taking infliximab for relapse within 12 months after discontinuing…
Pi della met dei pazienti con spondilite anchilosante (AS) che raggiunge la remissione clinica di malattia con infliximab e…
medwireNews : The decision to discontinue infliximab in ankylosing spondylitis (AS) patients who have achieved sustained…
12-04-2019 | Rheumatology | News | Article medwireNews: The decision to discontinue infliximab in ankylosing spondylitis (AS…
More than half of patients with ankylosing spondylitis (AS) who achieved clinical remission on infliximab (Remicade) relapsed…
More than half of patients with ankylosing spondylitis (AS) who achieved clinical remission on infliximab (Remicade) relapsed…
Recent data suggest that anti- TNF doses can be reduced in ankylosing spondylitis (AS) patients.